secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001104659-23-068910
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Therapeutics stockholders elect three Class II directors at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected Class II directors: Steven Hyman (20,552,674 for), James A. Geraghty (16,613,243 for), Alfred Sandrock (20,551,414 for); broker non-votes 8,405,461.
- Non-binding advisory say-on-pay approved with 20,162,995 for, 523,972 against, 33,553 abstain, and 8,405,461 broker non-votes.
- Ratified Ernst & Young as independent auditor for fiscal 2023 with 29,090,596 for, 32,521 against, 2,864 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465923068910/0001104659-23-068910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465923068910/tm2318122d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-068910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer